Dave Ricks, Eli Lilly CEO (Eli Lilly and Co.)

Eli Lil­ly ex­ecs have been think­ing about the longterm ef­fects of the pan­dem­ic and dam­age con­trol. Here’s what they be­lieve

Like a lot of Big Phar­ma out­fits, Eli Lil­ly has some in­ter­est­ing projects go­ing on for Covid-19. They have an ear­ly-stage an­ti­body pro­gram in play with a part­ner, tak­en Olu­mi­ant and start­ed work to see if it could help coro­n­avirus pa­tients. And they’ve mount­ed an am­bi­tious ef­fort to do lo­cal test­ing in their home base of In­di­anapo­lis, while be­ing one of the first of the ma­jor play­ers to out­line work-at-home rules to keep the virus from spread­ing in-house.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.